TIPRANAVIR vs TISLELIZUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
TIPRANAVIR vs TISLELIZUMAB: Safety Overview
| Metric | TIPRANAVIR | TISLELIZUMAB |
|---|---|---|
| Total FAERS Reports | 403 | 4,996 |
| Deaths Reported | 14 | 114 |
| Death Rate | 3.5% | 2.3% |
| Hospitalizations | 261 | 2,586 |
| Average Patient Age | 48.2 yrs | 62.9 yrs |
| % Female Patients | 82.9% | 26.5% |
| FDA Approval Date | Jun 22, 2005 | N/A |
| Manufacturer | Boehringer Ingelheim Pharmaceuticals,... | BeOne Medicines USA, Inc. |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Prescription | N/A |